Note 5 - Stock Purchase Warrants

3 Months Ended

Mar. 31, 2025

Note 5 – Stock Purchase Warrants

The following schedule reflects outstanding stock purchase warrants as of March 31, 2025 and December 31, 2024:

Description	March 31, 2025		March 31, 2024

2022 Sales incentive warrants	450,000			450,000
2024 Financing Participation warrant	-			500,000
Total		450,000		950,000

During the year ended December 31, 2022, we issued two warrants to purchase (i) 250,000 shares of common stock at an exercise price of $1.00 per share and expiring December 31, 2027 and (ii) 200,000 shares of common stock at an exercise price of $1.50 per share and expiring December 31, 2028 to a distribution partner under an agreement whereby the warrants were exercisable subject to the distributor attaining certain performance goals based upon exceeding sales quota revenues for calendar years 2023 through potentially 2025. According to the warrants' vesting provisions, they will not be exercisable throughout the remainder of their term. The warrants are equity classified. Additionally, we agreed to issue certain additional warrants to acquire up to 500,000 shares of common stock to the same distribution partner where the issuance of the warrant was contingent upon future financing events. This warrant was issued as of January 1, 2024 and exercised in its entirety by the holder during the year ended December 31, 2024. See Note 6 – Equity and Stock Based Compensation for further information.

Nuo Therapeutics, Inc. 10-Q